Rigel Pharmaceuticals Inc (RIGL) Company Long-Term Loans and Borrowings

Rigel Pharma - graphic logo of issuer RIGL

Rigel Pharmaceuticals (RIGL) is implementing automated laboratory systems for precise molecular analysis without human intervention. The company's business moat relies on exclusive FDA patents in the field of blood cancer treatment. This chart shows the market price on GURU.Markets at 0.00, while the company's financial stability is based on the commercialization of niche drugs and the development of new innovations.

RIGL Rigel Pharmaceuticals: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Rigel Pharmaceuticals Inc (RIGL)

- price and consensus price forecast:
Stock Price rigel.com|RIGL - Price Target Chart
- market capitalization data:
Market Value Rigel Pharmaceuticals|RIGL - Total Company Value
- book capitalization data:
Accounting Value per Share Rigel Pharmaceuticals|RIGL - Book Capitalization|Market Capitalization to Book Value Ratio rigel.com|RIGL - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Rigel Pharmaceuticals|RIGL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Rigel Corp|RIGL - Company Debts|Debt to Book Value Rigel Pharmaceuticals|RIGL - Company Long-Term Debt|Company Current Liabilities Rigel Pharmaceuticals
Fundamental company valuation:rigel.com (RIGL)
Original product of Rigel Pharmaceuticals

Long-term debt records obligations with maturities exceeding one year, allowing for an assessment of capital structure stability and the cost of servicing borrowed funds. By analyzing the corporation's long-term debt at the level of 0.00, an investor observes financial leverage that, for Rigel Pharmaceuticals (RIGL), is effectively offset by stable cash flow from the sale of a hematology drug portfolio characterized by a high rate of repeat prescriptions.

Competitor analysis for Rigel Pharmaceuticals

argenx.com - Company Long-Term Debts|Company Long-Term Debt BioNTech (BNTX)|ABVX: Company Long-Term Loans and Borrowings|ADMA (ADMA Bio) - Company Long-Term Debt|Protagonist Corp (PTGX) - Company Long-Term Liabilities|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Long-Term Debts CLDX|Aurinia Corp - Long-Term Debt Volume|BCRX: Company Long-Term Debt|VERA: Company Long-Term Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Long-Term Liabilities|Company Long-Term Debts TRML|Company Long-Term Debt Precigen, Inc. PGEN|Company Long-Term Indebtedness pharming.com (PHAR)|NKTR: Company Long-Term Debts|Upstream Bio, Inc. - Long-Term Debt|Company Long-Term Debt Zenas Biopharma, Inc. (ZBIO)|IMNM - Company Long-Term Loans and Borrowings|Gossamer Bio, Inc. - Company Long-Term Debts|kalvista.com (KALV) - Long-Term Debt Volume|Septerna - Company Long-Term Debts|Long-Term Indebtedness Pieris Pharma|Savara Corp - Company Long-Term Debts|Long-Term Debt ANAB (AnaptysBio Inc.)|Company Long-Term Debt Astria Therapeutics ATXS|ENGN - Company Long-Term Debt|Company Long-Term Liabilities RAPT Therapeutics, Inc. (RAPT)|JBIO: Company Long-Term Loans and Borrowings|Company Long-Term Debt Aclaris (ACRS)|Kyverna Therapeutics, Inc (KYTX) - Long-Term Liabilities|TLSA - Company Long-Term Debts|Company Long-Term Loans and Borrowings cabalettabio.com|Company Long-Term Debts VTYX|Company Long-Term Debts THTX (Theratechnologies, Inc.)|Company Long-Term Debt Avalo Therapeutics Inc.|Eledon Pharmaceuticals, Inc - Company Long-Term Loans and Borrowings|AGEN: Company Long-Term Debt|CLYM - Company Long-Term Liabilities|ZURA: Company Long-Term Debts|aTyr Pharma Inc (ATYR) - Company Long-Term Debts|Company Long-Term Debts ADAG|Company Long-Term Liabilities Ikena Oncology, Inc.|Shattuck Labs, Inc. - Company Long-Term Debts|Long-Term Debt equilliumbio.com EQ|Company Long-Term Liabilities CNTB (Connect Biopharma Holdings Limited)|IMUX - Company Long-Term Debts|Company Long-Term Liabilities Atara Biotherapeutics Inc ATRA|IFRX - Amount of Long-Term Liabilities|X4 Pharmaceuticals - Company Long-Term Debts|Adicet Bio, Inc. (ACET) - Long-Term Debt Volume|Company Long-Term Debts CELU|Company Long-Term Liabilities INmune Bio Inc|Company Long-Term Debts BRNS|Company Long-Term Debts KZR (Kezar Life Sciences Inc)|Company Long-Term Debt SAB Biotherapeutics SABS|akaritx.com - Company Long-Term Debt|Company Long-Term Debt ENLV (Enlivex Therapeutics, Ltd.)|QTTB: Long-Term Debt Volume|Company Long-Term Debt GeoVax Labs Inc GOVX|Edesa Biotech Corp (EDSA) - Company Long-Term Loans and Borrowings|IBIO: Company Long-Term Debts|Long-Term Debt Volume Carisma Tx|XTLB: Company Long-Term Debts|Long-Term Indebtedness BOLT (boltbio.com)|Company Long-Term Debt HCW Biologics HCWB|Aptevo Therapeutics, Inc. - Company Long-Term Debt|Company Long-Term Debt AIM ImmunoTech|ADTX - Long-Term Liabilities|Company Long-Term Debts GRI Bio GRI|XORTX Therapeutics Inc (XRTX) - Company Long-Term Loans and Borrowings|HIND (ReShape Lifesciences) - Company Long-Term Debts|Company Long-Term Debts REVB|Indaptus Therapeutics (INDP) - Company Long-Term Debt|Company Long-Term Loans and Borrowings SCNI (scinai.com)|CalciMedica - Company Long-Term Debt|Company Long-Term Liabilities Affimed NV AFMD|Allakos Therapeutics - Company Long-Term Debts|HOOKIPA Pharma Inc. (HOOK) - Company Long-Term Debts|Company Long-Term Liabilities igmbio.com IGMS|iteostherapeutics.com (ITOS) - Company Long-Term Loans and Borrowings|OCEA: Company Long-Term Debts|Long-Term Debt Volume TCBP|Company Long-Term Debt THRD (Third Harmonic Bio, Inc)